New research suggests that DNA variants help predict toxicity and response in CAR T-cell therapy for large B-cell lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback